Use Of Patented Traditional Chinese Medicine Against Covid-19.

• Author: Zhai, Huaqiang.
• TeilnehmendeR: Wang, Yanping.; Yang, Yiheng.; Li, Xiaodong.; Shao, Yingjun.
• Place / Publishing House: Singapore : : World Scientific Publishing Company,, 2021.; ©2021.
• Year of Publication: 2021
• Language: English
• Physical Description: 1 online resource (187 pages)

Table of Contents

Intro -- Contents -- Preface -- About the Editors-in-Chief -- Editorial Board -- Chapter 1 Understanding COVID-19 -- Section 1: Understanding of COVID-19 in Modern Medicine -- I. Basic Facts -- 1. Terminology -- 2. Pathogenic characteristics -- II. Epidemiological Characteristics -- 1. Source of infection -- 2. Transmission route -- 3. Susceptible population -- III. Clinical Features -- 1. Clinical manifestations -- 2. Auxiliary tests -- 3. Diagnostic criteria -- 3.1. Suspected cases -- 3.2. Confirmed cases -- 3.3. Standardized ICD code -- 4. Clinical classification -- 4.1. Mild cases -- 4.2. Common cases -- 4.3. Severe cases -- 4.4. Critical cases -- 5. Differential diagnosis -- Section 2: Understanding COVID-19 in Traditional Chinese Medicine -- I. Historical Review -- II. Disease Name -- III. Etiology and Pathogenesis -- IV. Treatment by Stages -- Chapter 2 Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia -- I. Etiological Characteristics -- II. Epidemiological Characteristics -- 1. Source of infection -- 2. Route of transmission -- 3. Susceptible population -- III. Pathological Changes -- 1. Lungs -- 2. Spleen, hilar lymph nodes, and bone marrow -- 3. Heart and blood vessels -- 4. Liver and gallbladder -- 5. Kidneys -- 6. Other organs -- IV. Clinical Characteristics -- 1. Clinical manifestations -- 2. Laboratory tests -- 2.1. General findings -- 2.2. Pathogenic and serological findings -- 3. Chest imaging -- V. Case Definitions -- 1. Suspected cases -- 1.1. Epidemiological history -- 1.2. Clinical manifestations -- 2. Confirmed cases -- VI. Clinical Classification -- 1. Mild cases -- 3. Severe adult cases meeting any of the following criteria -- 4. Critical cases -- VII. Early Clinical Warning Indicators of Severe and Critical Cases -- 1. Adults -- 2. Children -- VIII. Differential Diagnosis -- IX. Case Finding and Reporting.

X. Treatment -- 1. Treatment venue determined by the severity of the disease -- 2. General treatment -- 3. Treatment of severe and critical cases -- 3.1. Treatment principle -- 3.2. Respiratory support -- 3.3. Circulatory support -- 3.4. Renal failure and renal replacement therapy -- 3.5. Convalescent plasma treatment -- 3.6. Blood purification treatment -- 3.7. Immunotherapy -- 3.8. Other therapeutic measures -- 4. Traditional Chinese medicine treatment -- 4.1. During medical observation -- 4.2. During clinical treatment (confirmed cases) -- XI. Discharge Criteria and After-Discharge Considerations -- 1. Discharge criteria -- 2. After-discharge considerations -- XII. Patients Transportation Principles -- XIII. Nosocomial Infection Prevention and Control -- Chapter 3 Rational Use of Chinese Patent Medicine -- Section 1: Guiding Principles for the Clinical Application of Chinese Patent Medicine -- I. Safety of Chinese Patent Medicine -- II. Basic Principles of Clinical Application of Chinese Patent Medicine -- 1. Use medicines based on pattern diagnosis/syndrome differentiation -- 2. Medication selection based on both disease and pattern diagnosis -- 3. Selection of dosage form -- 4. Determination of dosage -- 5. Rational administration route -- 6. The use of Chinese medicine injection should also follow the below principles -- III. Principle for Combined Use -- 1. Combined use of Chinese patent medicines -- 2. Combined use of Chinese patent medicine and Western medicine -- IV. Principles of Use of Chinese Patent Medicine for Pregnant Women -- V. Principles for the Use of Chinese Patent Medicine Among Children -- Section 2: Contraindications in the Use of Chinese Patent Medicine -- I. Contraindicated Patterns/Syndromes -- II. Contraindicated Combination (Incompatibility) -- III. Contraindications During Pregnancy -- IV. Contraindications in Diet.

Section 3: Adverse Reactions and Adverse Events of Chinese Patent Medicine -- I. Factors Causing ADRs/ADEs of Chinese Patent Medicine -- 1. Medicines -- 1.1. The ingredients of traditional Chinese medicines -- 1.2. Misuse and Misapplication -- 1.3. Quality of medicinal substances -- 1.4. Improper processing or manufacturing -- 1.5. Non-standard package insert -- 2. Patients -- 2.1. Special populations -- 2.2. Idiosyncrasy -- 3. Clinical use -- 3.1. Inaccurate pattern diagnosis -- 3.2. Overdose and prolonged use -- 3.3. Improper combination -- II. Management of ADRs/ADEs of Chinese Patent Medicines -- 1. Right medicines for the right pattern -- 2. Knowing about the Chinese patent medicine before use -- 3. Treatment in accordance with season, region, and patient -- 4. Rational concomitant medications -- 5. Proper dosage &amp -- dosage forms -- Chapter 4 Guidance on Rational Application of Chinese Patent Medicine during Medical Observation Period -- Section 1: Huoxiang Zhengqi Capsule (see Table 3) (Pill, Water, Oral Liquid) -- I. Drug-Drug Interactions Among Concomitant Medications -- 1. Concomitant medications -- 1.1. The "eighteen clashes" in the combined use of Chinese herbal medicine -- 1.2. Combined use of Western medicines -- 2. Recommendations -- II. Pharmacological Action -- 1. Antispasmodic and analgesic effects -- 2. Immunity-enhancing effects -- 3. Gastrointestinal regulating effects -- 4. Anti-emetic effects -- 5. Anti-inflammatory effects -- 6. Antiviral effects -- 7. Bacteriostatic effects -- 8. Improving water, electrolyte, and metabolic disorders -- 9. Tranquilizing effects -- III. Pharmacist's Notes -- Section 2: Jinhua Qinggan Granule (see Table 3) -- I. Drug-Drug Interactions Among Concomitant Medications -- 1. Concomitant medications -- 1.1. The "eighteen clashes" in the combined use of Chinese herbal medicine.

1.2. Combined use of Western medicines -- 2. Recommendations -- II. Pharmacological Action -- 1. Antiviral effects -- 2. Anti-inflammatory effects -- 3. Immunity-enhancing effects -- III. Pharmacist's Notes -- Section 3: Lianhua Qingwen Capsule (Granule) (see Table 3) -- I. Drug-Drug Interactions Among Concomitant Medications -- 1. Issues in concomitant medications -- 2. Recommendations -- II. Pharmacological Action -- 1. Antiviral effects -- 2. Antibacterial effects -- 3. Immune Regulatory effects -- 4. Antipyretic and anti-inflammatory effects -- 5. Other effects -- III. Pharmacist's Notes -- Section 4: Shufeng Jiedu Capsule (see Table 3) -- I. Drug-Drug Interactions Among Concomitant Medications -- II. Pharmacological Action -- 1. Antiviral effects -- 2. Antibacterial effect -- 3. Antipyretic effect -- 4. Anti-inflammatory and immunomodulatory effects -- 5. Analgesic effect -- III. Pharmacist's Notes -- Chapter 5 Guidance on Rational Application of Chinese Patent Medicine during Clinical Treatment Period -- Section 1: Xiyanping Injection (see Table 1) -- I. Administration and Dosage -- II. Drug-Drug Interactions Among Concomitant Medications -- 1. Issues of concomitant medications -- 2. Recommendations -- III. Pharmacological Action -- 1. Antiviral effects -- 2. Antibacterial effects -- 3. Antitussive effects -- 4. Anti-inflammatory and antipyretic effects -- 5. Immunity-enhancing effects -- IV. Pharmacist's Notes -- Section 2: Tanreqing Injection (see Table 1) -- I. Administration and Dosage -- II. Drug-Drug Interactions Among Concomitant Medications -- 1. Issues in concomitant medications -- 2. Recommendations -- III. Pharmacological Action -- 1. Antibacterial and antiviral effects -- 2. Anti-inflammatory and antipyretic effects -- 3. Antitussive effects -- 4. Spasmolysis -- 5. Immunity-enhancing effects -- 6. Apoptosis-promoting effects.

IV. Pharmacist's Notes -- Section 3: Xuebijing Injection (see Table 1) -- I. Administration and Dosage -- II. Drug-Drug Interactions Among Concomitant Medications -- 1. Issues in mixed administration -- 1.1 The "eighteen clashes" in the combined use of Chinese herbal medicine -- 1.2 Combined use of Western medicines -- 2. Recommendations -- III. Pharmacological Action -- 1. Improving blood coagulation -- 2. Anti-endotoxin effects -- 3. Phagocytosis-improving effects -- 4. Anti-inflammatory effects -- 5. Immune-regulating effects -- 6. Protect and repair damaged organs -- IV. Pharmacist's Notes -- Section 4: Xingnaojing Injection (see Table 1) -- I. Administration and Dosage -- II. Drug-Drug Interactions Among Concomitant Medications -- 1. Issues in concomitant medications -- 2. Recommendations -- III. Pharmacological Action -- 1. Regulating central nervous system -- 2. Brain protection -- 3. Reducing brain edema -- 4. Improving brain microcirculation -- 5. Antiepileptic effects -- 6. Anti-angina effects -- IV. Pharmacist's Notes -- Section 5: Reduning Injection (see Table 1) -- I. Administration and Dosage -- II. Mixed Administration -- 1. Issues in concomitant medications -- 2. Recommendations -- III. Pharmacological Action -- 1. Antipyretic effects -- 2. Antiviral effects -- 3. Antibacterial effects -- 4. Anti-inflammatory effects -- 5. Analgesic effects -- 6. Immunity-enhancing effects -- IV. Pharmacist's Notes -- Section 6: Shengmai Injection (see Table 1) -- I. Administration and Dosage -- II. Drug-Drug Interactions Among Concomitant Medications -- 1. Issues in concomitant medications -- 1.1. The "eighteen clashes" and "nineteen incompatibilities" in the combined use of Chinese herbal medicine -- 1.2. Combined use of Western medicines -- 2. Recommendations -- III. Pharmacological Action -- 1. Immunity-enhancing effects.

2. Protecting the heart muscle.